Cargando…

Changes in metabolic risk factors over 10 years and their associations with late-life cognitive performance: The Multi-Ethnic Study of Atherosclerosis

BACKGROUND: We examined whether changes in metabolic factors over 10 years were associated with cognitive performance. METHODS: Participants from the Multi-Ethnic Study of Atherosclerosis were followed since baseline (2000–2002) with five clinical examinations. At exam 5 (2010–2012), they received a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hughes, Timothy M., Craft, Suzanne, Baker, Laura D., Espeland, Mark A., Rapp, Stephen R., Sink, Kaycee M., Bertoni, Alain G., Burke, Gregory L., Gottesman, Rebecca F., Michos, Erin D., Luchsinger, José A., Fitzpatrick, Annette L., Hayden, Kathleen M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Diagnostic Assessment & Prognosis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390661/ https://www.ncbi.nlm.nih.gov/pubmed/28435852 http://dx.doi.org/10.1016/j.dadm.2017.03.003

Ejemplares similares

Mild cognitive impairment and dementia prevalence: The Atherosclerosis Risk in Communities Neurocognitive Study
por: Knopman, David S., et al.
Publicado: (2016)

Dual sensory impairment in older adults and risk of dementia from the GEM Study
por: Hwang, Phillip H., et al.
Publicado: (2020)

Is diabetes associated with increased pathological burden in Alzheimer's disease?
por: Sadrolashrafi, Kaviyon, et al.
Publicado: (2021)

Patterns of glucose hypometabolism in Down syndrome resemble sporadic Alzheimer's disease except for the putamen
por: Zammit, Matthew D., et al.
Publicado: (2021)

The Wisconsin Registry for Alzheimer's Prevention: A review of findings and current directions
por: Johnson, Sterling C., et al.
Publicado: (2017)

Meeting physical activity recommendations may be protective against temporal lobe atrophy in older adults at risk for Alzheimer's disease
por: Dougherty, Ryan J., et al.
Publicado: (2016)

Insulin resistance is related to cognitive decline but not change in CSF biomarkers of Alzheimer's disease in non‐demented adults
por: Ennis, Gilda E., et al.
Publicado: (2021)

Prediction of poor clinical outcome in vascular cognitive impairment: TRACE‐VCI study
por: Boomsma, Jooske M.F., et al.
Publicado: (2020)

Alzheimer's disease severity, objectively determined and measured
por: Gross, Alden L., et al.
Publicado: (2016)

Neuropsychiatric symptoms in Brazilians with mild cognitive impairment and dementia
por: Wilson, Robert S., et al.
Publicado: (2021)

Cerebrospinal fluid biomarkers of Alzheimer's disease in a cohort of adults with Down syndrome
por: Henson, Rachel L., et al.
Publicado: (2020)

The Role of Inflammation after Surgery for Elders (RISE) study: Study design, procedures, and cohort profile
por: Hshieh, Tammy T., et al.
Publicado: (2019)

Moderate intensity physical activity associates with CSF biomarkers in a cohort at risk for Alzheimer's disease
por: Law, Lena L., et al.
Publicado: (2018)

Development and internal validation of a predictive model of cognitive decline 36 months following elective surgery
por: Jones, Richard N., et al.
Publicado: (2021)

Normative data for the Brief Spanish‐English Verbal Learning Test for representative and diverse Hispanics/Latinos: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
por: Breton, Jordana, et al.
Publicado: (2021)

Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans
por: Jutkowitz, Eric, et al.
Publicado: (2020)

Evaluation of the ATN model in a longitudinal memory clinic sample with different underlying disorders
por: Eckerström, C., et al.
Publicado: (2021)

General practitioners’ attitude toward early and pre‐dementia diagnosis of AD in five European countries—A MOPEAD project survey
por: Sannemann, Lena, et al.
Publicado: (2021)

Pilot study of an Alzheimer's disease risk assessment program in a primary care setting
por: Korthauer, Laura E., et al.
Publicado: (2021)

Predicting time to dementia using a quantitative template of disease progression
por: Bilgel, Murat, et al.
Publicado: (2019)

Amyloid positron emission tomography candidates may focus more on benefits than risks of results disclosure
por: Lingler, Jennifer H., et al.
Publicado: (2018)

Dementia with Lewy bodies research consortia: A global perspective from the ISTAART Lewy Body Dementias Professional Interest Area working group
por: D'Antonio, Fabrizia, et al.
Publicado: (2021)

Function and clinical meaningfulness of treatments for mild Alzheimer's disease
por: Siemers, Eric, et al.
Publicado: (2016)

The power of knowledge about dementia in Latin America across health professionals working on aging
por: Ibanez, Agustin, et al.
Publicado: (2020)

Age at injury is associated with the long-term cognitive outcome of traumatic brain injuries
por: Li, Wei, et al.
Publicado: (2017)

Detecting functional decline from normal aging to dementia: Development and validation of a short version of the Amsterdam IADL Questionnaire
por: Jutten, Roos J., et al.
Publicado: (2017)

Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and design
por: de Wilde, Arno, et al.
Publicado: (2017)

The incidence of mild cognitive impairment: A systematic review and data synthesis
por: Gillis, Cai, et al.
Publicado: (2019)

An individual with human immunodeficiency virus, dementia, and central nervous system amyloid deposition
por: Turner, Raymond Scott, et al.
Publicado: (2016)

Evaluating combinations of diagnostic tests to discriminate different dementia types
por: Bruun, Marie, et al.
Publicado: (2018)

Women's higher brain metabolic rate compensates for early Alzheimer's pathology
por: Sundermann, Erin E., et al.
Publicado: (2020)

Multi‐time‐point data preparation robustly reveals MCI and dementia risk factors
por: Kaur, Daman, et al.
Publicado: (2020)

Fusion of deep learning models of MRI scans, Mini–Mental State Examination, and logical memory test enhances diagnosis of mild cognitive impairment
por: Qiu, Shangran, et al.
Publicado: (2018)

Development and validation of a salivary tau biomarker in Alzheimer's disease
por: Pekeles, Heather, et al.
Publicado: (2018)

Disclosure of preclinical Alzheimer's disease biomarker results in research and clinical settings: Why, how, and what we still need to know
por: Erickson, Claire M., et al.
Publicado: (2021)

Practical algorithms for amyloid β probability in subjective or mild cognitive impairment
por: Maserejian, Nancy, et al.
Publicado: (2019)

Clinician-patient communication during the diagnostic workup: The ABIDE project
por: Visser, Leonie N.C., et al.
Publicado: (2019)

Revolutionizing Alzheimer's disease and clinical trials through biomarkers
por: Mattsson, Niklas, et al.
Publicado: (2015)

Metabolic correlates of prevalent mild cognitive impairment and Alzheimer's disease in adults with Down syndrome
por: Mapstone, Mark, et al.
Publicado: (2020)

Incidence of mild cognitive impairment in World Trade Center responders: Long-term consequences of re-experiencing the events on 9/11/2001
por: Clouston, Sean A.P., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8jronas3ui5enret1hk99fg8md